{"id":"NCT00622336","sponsor":"Celgene","briefTitle":"A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma","officialTitle":"Open-Label, Single-Arm Study of the Safety and Efficacy of CC-5013 Monotherapy for Subjects With Multiple Myeloma: A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-04-01","primaryCompletion":"2013-11-25","completion":"2013-11-25","firstPosted":"2008-02-25","resultsPosted":"2014-12-30","lastUpdate":"2019-11-20"},"enrollment":330,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"CC-5013","otherNames":["Revlimid","lenalidomide"]},{"type":"DRUG","name":"Lenalidomide","otherNames":["Revlimid","CC-5013"]}],"arms":[{"label":"Lenalidomide 25mg (CC-5013)","type":"EXPERIMENTAL"}],"summary":"The study evaluated the safety of Lenalidomide monotherapy in participants with advanced multiple myeloma who had discontinued treatment with combination thalidomide plus high-dose dexamethasone or high-dose dexamethasone alone in studies Thal-MM-003, CC-5013-MM-009 and CC-5013-MM-010 due to the development of documented disease progression or the inability to tolerate the lowest dosing regimen per previous protocol of thalidomide and/or high-dose dexamethasone without grade 3 or 4 toxicity.","primaryOutcome":{"measure":"Number of Participants With Adverse Events (AE) During the Treatment Phase","timeFrame":"Until data cut-off of 22 Oct 2009; AEs/SAEs were recorded from informed consent to 30 days post treatment discontinuation visit. Maximum exposure to Lenalidomide treatment was 1260 days.","effectByArm":[{"arm":"Lenalidomide 25mg (CC-5013)","deltaMin":327,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":10},"locations":{"siteCount":7,"countries":["Russia","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":177,"n":330},"commonTop":["Asthenia","Headache","Anaemia NOS"]}}